Pharma major Cadila Healthcare Ltd received approval from Drugs Controller General of India (DCGI) to use a Hepatitis C drug as a treatment for Covid-19, the drugmaker said on Friday.
More to follow
Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks